https://www.frontiersin.org/journals/neurology/articles/10.3389/fneur.2024.1540452/full
Frontiers | Corrigendum: Cipaglucosidase alfa plus miglustat: linking mechanism of action to...
Corrigendum on: Byrne BJ, Parenti G, Schoser B, van der Ploeg AT, Do H, Fox B, Goldman M, Johnson FK, Kang J, Mehta N, Mondick J, Sheikh MO, Sitaraman Das S,...
mechanism of actionalfa plusfrontierscorrigendum
https://profiles.wustl.edu/en/publications/phase-iii-trial-of-bevacizumab-plus-interferon-alfa-versus-interf/
Phase III trial of bevacizumab plus interferon alfa versus interferon alfa monotherapy in patients...
phase iii